Healthcare provider profile · identity verified

Andrew H Balder, MD

Internal Medicine · SPRINGFIELD, MA · NPI 1720188832

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	445	90
Omeprazole	Omeprazole	300	50
Amlodipine Besylate	Amlodipine Besylate	286	56
Oxycodone Hcl	Oxycodone Hcl	277	47
Gabapentin	Gabapentin	236	38
Levothyroxine Sodium	Levothyroxine Sodium	196	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	177	40
Lisinopril	Lisinopril	170	33
Trulicity	Dulaglutide	168	30
Jardiance	Empagliflozin	152	23
Pantoprazole Sodium	Pantoprazole Sodium	136	26
Losartan Potassium	Losartan Potassium	134	27
Albuterol Sulfate Hfa	Albuterol Sulfate	125	33
Fluticasone Propionate	Fluticasone Propionate	120	28
Metformin Hcl	Metformin Hcl	116	24
Pregabalin	Pregabalin	116	14
Tamsulosin Hcl	Tamsulosin Hcl	107	22
Clonazepam	Clonazepam	105	12
Furosemide	Furosemide	105	16
Eliquis	Apixaban	99	15
Montelukast Sodium	Montelukast Sodium	97	18
Hydrochlorothiazide	Hydrochlorothiazide	88	22
Metformin Hcl Er	Metformin Hcl	88	23
Tramadol Hcl	Tramadol Hcl	84	18
Hydroxyzine Hcl	Hydroxyzine Hcl	83	13
Metoprolol Succinate	Metoprolol Succinate	82	15
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	81	suppressed
Farxiga	Dapagliflozin Propanediol	81	14
Novolog Flexpen	Insulin Aspart	81	14
Duloxetine Hcl	Duloxetine Hcl	74	12
Ventolin Hfa	Albuterol Sulfate	73	19
Famotidine	Famotidine	67	11
Xarelto	Rivaroxaban	67	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	66	11
Ozempic	Semaglutide	66	12
Lorazepam	Lorazepam	60	suppressed
Clonidine Hcl	Clonidine Hcl	59	12
Diclofenac Sodium	Diclofenac Sodium	58	19
Trazodone Hcl	Trazodone Hcl	56	13
Carvedilol	Carvedilol	55	17
Clopidogrel	Clopidogrel Bisulfate	53	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	51	16
Simvastatin	Simvastatin	49	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	49	suppressed
Spironolactone	Spironolactone	48	11
Quetiapine Fumarate	Quetiapine Fumarate	46	suppressed
Lidocaine	Lidocaine	45	suppressed
Mirtazapine	Mirtazapine	44	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Torsemide	Torsemide	40	suppressed
Testosterone Cypionate	Testosterone Cypionate	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	38	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	35	suppressed
Ibuprofen	Ibuprofen	35	suppressed
Chlorthalidone	Chlorthalidone	34	suppressed
Meloxicam	Meloxicam	34	suppressed
Glipizide Er	Glipizide	33	suppressed
Diazepam	Diazepam	32	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	31	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Sertraline Hcl	Sertraline Hcl	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Prednisone	Prednisone	29	15
Lidocaine-Prilocaine	Lidocaine/Prilocaine	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Unifine Pentips Plus	Pen Needle, Diabetic	27	suppressed
Allopurinol	Allopurinol	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Novolog	Insulin Aspart	25	suppressed
Symtuza	Darunavir/Cob/Emtri/Tenof Alaf	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Atenolol	Atenolol	24	suppressed
Baclofen	Baclofen	24	suppressed
Entresto	Sacubitril/Valsartan	24	suppressed
Buprenorphine	Buprenorphine	23	suppressed
Celecoxib	Celecoxib	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Incruse Ellipta	Umeclidinium Bromide	23	suppressed
Topiramate	Topiramate	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Varenicline Tartrate	Varenicline Tartrate	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Clotrimazole	Clotrimazole	21	11
Prazosin Hcl	Prazosin Hcl	21	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	20	suppressed
Naproxen	Naproxen	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Nystatin	Nystatin	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Morphine Sulfate	Morphine Sulfate	18	suppressed
Finasteride	Finasteride	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Icosapent Ethyl	Icosapent Ethyl	17	suppressed
Indomethacin	Indomethacin	17	suppressed
Minoxidil	Minoxidil	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Glipizide	Glipizide	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Testosterone	Testosterone	15	suppressed
Estradiol	Estradiol	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Amiloride Hcl	Amiloride Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Erythromycin	Erythromycin Base	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Naltrexone Hcl	Naltrexone Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
True Comfort Safety Pen Needle	Pen Needle, Diabetic, Safety	13	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Prezcobix	Darunavir/Cobicistat	12	suppressed
Tivicay	Dolutegravir Sodium	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
V-Go 20	Sub-Q Insulin Device, 20 Unit	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error